Posts Tagged ‘Food and Drug Administration’

The U.S. Food and Drug Administration reported finding low levels of fungicide carbendazim in orange juice headed for U.S. supermarkets, but assured the public the juice remains safe to drink.

After being alerted by Coca Cola, the owner of Minute Maid and Simple Orange brands of orange juice, that certain juice from Brazil had tested positive for the fungicide in January, FDA initiated testing of all orange juice imports, regardless of origin.

The fungicide, which is used to combat unsightly mold, is not allowed in the United States, but used widely elsewhere. The United States has a carbendazim tolerance for several fruits, but not orange juice.

“FDA is continuing to ensure that orange juice in the United States does not pose a safety concern due to the presence of carbendazim residues,” the agency said in an update Thursday. “Based on all results we have seen to date, we remain confident that orange juice in the U.S. may be consumed without concerns about its safety due to the possible presence of such residues.”

SOURCE

https://truthsupport.files.wordpress.com/2012/02/antibioticmeats-210x131.jpg?w=210
Andre Evans
Activist Post

Meat is a staple food in the diet of many across the world. Whether or not you chooses to eat meat, its widespread consumption is undeniable.

Many meat-eaters opt to purchase organic meat in order to avoid the cocktail of hormones, additives, and other unwanted ingredients that go along with conventional meat products.

Despite this, the many forms of meat products are largely contaminated and have their own host of issues — including ‘antibiotic-free’ meats, according to a new report.

CLICK FOR FULL STORY

In another outrageous power-grab, FDA says your own stem cells are drugs–and stem cell therapy is interstate commerce because it affects the bottom line of FDA-approved drugs in other states!

We wish this were a joke, but it’s the US Food and Drug Administration’s latest claim in its battle with a Colorado clinic over its Regenexx-SD™ procedure, a non-surgical treatment for people suffering from moderate to severe joint or bone pain using adult stem cells.

The FDA asserts in a court document that it has the right to regulate the Centeno-Schultz Clinic for two reasons:

Stem cells are drugs and therefore fall within their jurisdiction. (The clinic argues that stem cell therapy is the practice of medicine and is therefore not within the FDA’s jurisdiction!)
The clinic is engaging in interstate commerce and is therefore subject to FDA regulation because any part of the machine or procedure that originates outside Colorado becomes interstate commerce once it enters the state. Moreover, interstate commerce is substantially affected because individuals traveling to Colorado to have the Regenexx procedure would “depress the market for out-of-state drugs that are approved by FDA.”
We discussed the very ambiguous issue of interstate commerce last September–it’s an argument the FDA frequently uses when the basis for their claim is otherwise lacking. As we noted then, the FDA holds that an “interstate commerce” test must be applied to all steps in a product’s manufacture, packaging, and distribution. This means that if any ingredient or tool used in the procedure in question was purchased out of state, the FDA would in its view have jurisdiction, just as they would if the final product had traveled across state lines.

 CLICK FOR FULL STORY

Via: Washington Post:

The Food and Drug Administration secretly monitored the personal e-mail of a group of its own scientists and doctors after they warned Congress that the agency was approving medical devices that they believed posed unacceptable risks to patients, government documents show.

The surveillance — detailed in e-mails and memos unearthed by six of the scientists and doctors, who filed a lawsuit against the FDA in U.S. District Court in Washington last week — took place over two years as the plaintiffs accessed their personal Gmail accounts from government computers.

Information garnered this way eventually contributed to the harassment or dismissal of all six of the FDA employees, the suit alleges. All had worked in an office responsible for reviewing devices for cancer screening and other purposes.

CLICK FOR FULL STORY

https://i1.wp.com/www.theweedblog.com/wp-content/uploads//fda-medical-marijuana.jpg

Saturday, January 28, 2012 by: Jonathan Benson, staff writer

(NaturalNews) The pressure is on for researchers and pharmaceutical companies to develop drug-based, non-synthetic versions of marijuana for medical use, as the US Food and Drug Administration (FDA) is poised to approve such varieties in the near future. But this potential approval appears to be reserved only for Big Pharma, as the marijuana plant itself could continue to remain a controlled substance at the federal level with no recognized health benefits.

The Associated Press (AP) reports that GW Pharma, a British pharmaceutical company, is currently undergoing advanced clinical trials for the world’s first drug made from raw marijuana, which it will seek FDA approval for by the end of 2013. There are currently a number of synthetic cannabinoid drugs on the market that have been approved by the FDA, but none that incorporate actual marijuana (http://www.justice.gov/dea/ongoing/marinol.html).

Known as Sativex, the marijuana spray contains both delta 9-tetrahydrocannabinol (THC) and cannabidiol, which are considered to be raw marijuana’s two most well-known active components. GW Pharma is hoping to receive US FDA approval of Sativex for the treatment of cancer pain, as the drug has already been approved in several other countries for the treatment of muscle spasm pain caused by multiple sclerosis.

 CLICK FOR FULL STORY

by Gretchen Goetz
FOOD SAFETY NEWS

A controversial animal drug, fed to a majority of pigs raised in the United States, has become the focus of a long-running trade dispute centered on meat exports.

Ractopamine hydrochloride – used to keep swine lean and boost their growth in the last weeks before slaughter – is administered to an estimated 60 to 80 percent of pigs raised in the United States. But key trading partners,want assurance that it is safe, and have a zero-tolerance policy for meats with even traces of the substance. So export markets are limited, according to a report published Wednesday by msnbc.com.

The feed additive is also responsible for more deaths and illnesses among pigs than any other livestock drug on the market. It has killed or sickened more than 218,000 pigs since it was introduced, according to the analysis in Business on msnbc.com this week.

The U.S. Food and Drug Administration (FDA) determined that ractopamine was safe for use in pigs 13 years ago – in 1999 – and has since approved it for use in cattle and turkeys as well.
The agency set a threshold for residues of the drug. Sale of any meat with levels below this amount are legal-
But testing for ractopamine in meat products has been limited. In 2010, for example, 712 samples were taken from 26 billion pounds of beef, and the results of this testing have not yet been released.

http://www.foodsafetynews.com/2012/01/a-controversial-animal-drug-banned/

Anthony Gucciardi
Activist Post

Why are ineffective and dangerous drugs peddled by supposed ‘public health’ organizations in place of well-established natural solutions with virtually zero side effects?

The truth of the matter is that drug makers simply would not profit if the world were to awaken to the plethora of free health-promoting substances that beat out over-priced pharmaceuticals and medical interventions. There would be no need for pharmaceutical manufacturers, phony ‘public health’ organizations peddling the latest ‘miracle’ drug, and certainly no research organizations feeding off the donations of good-hearted individuals.

You may think that this is an impossibility and that natural solutions simply do not compare to ‘scientifically proven’ pharmaceutical science. The truth of the matter is that scientific evidence is the very thing disproving the safety and effectiveness of pharmaceutical drugs, as well as highlighting the surplus of beneficial properties associated with inexpensive and free vital nutrients.

CLICK FOR FULL STORY